Article

p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins.

Department of Pathophysiology, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin 130021, PR China.
European journal of cancer (Oxford, England: 1990) (impact factor: 4.12). 03/2011; 47(10):1585-94. DOI:10.1016/j.ejca.2011.01.019 pp.1585-94
Source: PubMed

ABSTRACT Mechanisms of cisplatin resistance in cancer cells are not fully understood. Here, we show a critical role for the ubiquitin-binding protein p62/SQSTM1 in cisplatin resistance in human ovarian cancer cells (HOCCs). Specifically, we found that cisplatin-resistant SKOV3/DDP cells express much higher levels of p62 than do cisplatin-sensitive SKOV3 cells. The protein p62 binds ubiquitinated proteins for transport to autophagic degradation, reducing apoptosis induced by endoplasmic reticulum (ER) stress in SKOV3/DDP cells. Knockdown of p62 or inhibition of autophagy using 3-methyladenine resensitises SKOV3/DDP cells to cisplatin. Collectively, our data indicate that p62 acts as a receptor or adaptor for autophagic degradation of ubiquitinated proteins, and plays an important role in preventing ER stress-induced apoptosis, leading to cisplatin resistance in HOCCs.

0 0
 · 
0 Bookmarks
 · 
70 Views

Keywords

3-methyladenine resensitises SKOV3/DDP cells
 
apoptosis induced
 
cisplatin
 
cisplatin resistance
 
cisplatin-resistant SKOV3/DDP cells
 
cisplatin-sensitive SKOV3 cells
 
critical role
 
endoplasmic reticulum
 
human ovarian cancer cells
 
Knockdown
 
protein p62 binds ubiquitinated proteins
 
receptor
 
ubiquitin-binding protein p62/SQSTM1
 
ubiquitinated proteins